Insulin aspart, recombinant Subcutaneous and Omnicef (Cefdinir Capsules)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Omnicef (Cefdinir Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: cefdinir
Brand name: Omnicef, Omnicef Omni-Pac
Synonyms: Omnicef
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Omnicef (Cefdinir Suspension)
- Insulin aspart, recombinant Subcutaneous-Omnicef Omni-Pac
- Insulin aspart, recombinant Subcutaneous-Omnipaque
- Insulin aspart, recombinant Subcutaneous-Omnipaque 12
- Insulin aspart, recombinant Subcutaneous-Omnipaque 9
- Insulin aspart, recombinant Subcutaneous-Omnipaque Injection
- Omnicef (Cefdinir Capsules)-Insulin degludec
- Omnicef (Cefdinir Capsules)-Insulin Degludec (U-100) Prefilled Pens
- Omnicef (Cefdinir Capsules)-Insulin Degludec (U-100) Vials
- Omnicef (Cefdinir Capsules)-Insulin Degludec (U-200) Prefilled Pens
- Omnicef (Cefdinir Capsules)-Insulin degludec and liraglutide
- Omnicef (Cefdinir Capsules)-Insulin degludec and liraglutide Subcutaneous